Trials / Recruiting
RecruitingNCT07277257
Evaluating a New Therapy for Dry Eye in Patients With Sjögren's Syndrome
Evaluating TRYPTYR as a Novel Therapy for Dry Eye in Patients With Sjögren's Syndrome
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 35 (estimated)
- Sponsor
- Center For Sight · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the effect of TRYPTYR in patients with Sjögren's syndrome-related dry eye disease. The goal is to determine whether TRYPTYR can improve symptoms and signs of dry eye in this specific patient population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TRYPTYR (Acoltremon ophthalmic solution 0.003%) | Drop to be instilled before and after endpoint measurement. |
Timeline
- Start date
- 2025-12-02
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
- First posted
- 2025-12-11
- Last updated
- 2025-12-22
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07277257. Inclusion in this directory is not an endorsement.